Search Page

1

Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review.

Dimitrakopoulou-Strauss A, Ronellenfitsch U, Cheng C, Pan L, Sachpekidis C, Hohenberger P, Henzler T. Dimitrakopoulou-Strauss A, et al. Among authors: Sachpekidis C. Clin Transl Imaging. 2017;5(3):183-197. doi: 10.1007/s40336-017-0229-8. Epub 2017 May 3. Clin Transl Imaging. 2017. PMID: 29104864 Free PMC article. Review.

Cite

Share

2

¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C. Smailagic N, et al. Among authors: Sachpekidis C. Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article. Review.

Cite

Share

3

⁶⁸Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer.

Sachpekidis C, Bäumer P, Kopka K, Hadaschik BA, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):904-912. doi: 10.1007/s00259-018-3936-0. Epub 2018 Jan 23. Eur J Nucl Med Mol Imaging. 2018. PMID: 29362859

Cite

Share

4

Equilibrium radionuclide ventriculography: still a clinically useful method for the assessment of cardiac function?

Sachpekidis C, Sachpekidis V, Moralidis E, Arsos G. Sachpekidis C, et al. Among authors: Sachpekidis V. Hell J Nucl Med. 2018 Sep-Dec;21(3):213-220. Hell J Nucl Med. 2018. PMID: 30534636 Free article. Review.

Cite

Share

5

The role of interim ¹⁸F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.

Sachpekidis C, Anwar H, Winkler J, Kopp-Schneider A, Larribere L, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1289-1296. doi: 10.1007/s00259-018-3972-9. Epub 2018 Feb 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 29478079 Clinical Trial.

Cite

Share

6

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Sachpekidis C, Goldschmidt H, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Molecules. 2019 Dec 29;25(1):134. doi: 10.3390/molecules25010134. Molecules. 2019. PMID: 31905752 Free PMC article. Review.

Cite

Share

7

Absolute number of new lesions on ¹⁸F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.

Anwar H, Sachpekidis C, Winkler J, Kopp-Schneider A, Haberkorn U, Hassel JC, Dimitrakopoulou-Strauss A. Anwar H, et al. Among authors: Sachpekidis C. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):376-383. doi: 10.1007/s00259-017-3870-6. Epub 2017 Nov 10. Eur J Nucl Med Mol Imaging. 2018. PMID: 29124281 Clinical Trial.

Cite

Share

8

68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer.

Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Clin Nucl Med. 2016 Nov;41(11):e473-e479. doi: 10.1097/RLU.0000000000001349. Clin Nucl Med. 2016. PMID: 27607173 Free article.

Cite

Share

9

Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib.

Sachpekidis C, Hassel JC, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Hell J Nucl Med. 2017 Sep-Dec;20(3):251-253. doi: 10.1967/s002449910611. Epub 2017 Nov 27. Hell J Nucl Med. 2017. PMID: 29177265 Free article.

Cite

Share

10

18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst.

Sachpekidis C, Dettmer MS, Weidner S, Giger R, Wartenberg J. Sachpekidis C, et al. Clin Nucl Med. 2017 Aug;42(8):e371-e374. doi: 10.1097/RLU.0000000000001712. Clin Nucl Med. 2017. PMID: 28525461 Free article.

Cite

Share